These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7508268)

  • 41. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG; Marks JW; Cheung LH
    Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
    Sanderson RJ; Hering MA; James SF; Sun MM; Doronina SO; Siadak AW; Senter PD; Wahl AF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):843-52. PubMed ID: 15701875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin.
    Liu L; Zhang C; Li Z; Wang C; Bi J; Yin S; Wang Q; Yu R; Liu Y; Su Z
    Mol Pharm; 2017 Nov; 14(11):3739-3749. PubMed ID: 28950700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate.
    Di Stefano G; Lanza M; Kratz F; Merina L; Fiume L
    Eur J Pharm Sci; 2004 Dec; 23(4-5):393-7. PubMed ID: 15567293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An intramolecular cyclization reaction is responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin.
    Lee CC; Cramer AT; Szoka FC; Fréchet JM
    Bioconjug Chem; 2006; 17(5):1364-8. PubMed ID: 16984149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.
    Graeser R; Esser N; Unger H; Fichtner I; Zhu A; Unger C; Kratz F
    Invest New Drugs; 2010 Feb; 28(1):14-9. PubMed ID: 19148580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BR96 conjugates of highly potent anthracyclines.
    King HD; Staab AJ; Pham-Kaplita K; Yurgaitis D; Firestone RA; Lasch SJ; Trail PA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2119-22. PubMed ID: 12798317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and characterization of carbohydrate-linked murine monoclonal antibody K20-human serum albumin conjugates.
    Kondejewski LH; Kralovec JA; Blair AH; Ghose T
    Bioconjug Chem; 1994; 5(6):602-11. PubMed ID: 7873663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA.
    Post GC; Barthel BL; Burkhart DJ; Hagadorn JR; Koch TH
    J Med Chem; 2005 Dec; 48(24):7648-57. PubMed ID: 16302805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of coupling bonds on the anti-tumor activity of polymer-pirarubicin conjugates.
    Mo G; Hu X; Liu S; Yue J; Wang R; Huang Y; Jing X
    Eur J Pharm Sci; 2012 Aug; 46(5):329-35. PubMed ID: 22426082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiol-containing cross-linking agent with enhanced steric hindrance.
    Greenfield L; Bloch W; Moreland M
    Bioconjug Chem; 1990; 1(6):400-10. PubMed ID: 2129154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo.
    Kaneta Y; Tsukazaki K; Kubushiro K; Sakayori M; Ueda M; Nozawa S
    Oncol Rep; 2000; 7(5):1099-106. PubMed ID: 10948346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
    Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
    J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin.
    Wahl AF; Donaldson KL; Mixan BJ; Trail PA; Siegall CB
    Int J Cancer; 2001 Aug; 93(4):590-600. PubMed ID: 11477565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
    Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
    J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N,N'-methylenebis(acrylamide)-crosslinked poly(acrylic acid) particles as doxorubicin carriers: A comparison between release behavior of physically loaded drug and conjugated drug via acid-labile hydrazone linkage.
    Modarresi-Saryazdi SM; Haddadi-Asl V; Salami-Kalajahi M
    J Biomed Mater Res A; 2018 Feb; 106(2):342-348. PubMed ID: 28921847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
    Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
    Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of immunoconjugates for antibody-targeted photolysis.
    Rakestraw SL; Tompkins RG; Yarmush ML
    Bioconjug Chem; 1990; 1(3):212-21. PubMed ID: 1710935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.
    Remsen LG; Trail PA; Hellström I; Hellström KE; Neuwelt EA
    Neurosurgery; 2000 Mar; 46(3):704-9. PubMed ID: 10719867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.